19
May 22
Startups and Sustainability: Interview with MUGO
Our “Startups and Sustainability” interview series continues with a third guest.
For this episode, we had the pleasure of interviewing Benedetto Ruggeri, co-founder and CEO of MUGO. The company’s goal? To create the first climate-neutral generation.
6
May 22
The New Insolvency Code: A new era for innovative startups
As of today, insolvent innovative startups are subject to a special regulation, different from the one generally provided for commercial companies.
26
Apr 22
Structuring venture capital transactions in US, UK, and Italy
Portolano Cavallo and Wilson Sonsini are excited to partner on a webinar discussion to share experiences on the similarities and differences in US, UK and Italian markets with respect to:
structuring VC transactions (e.g., SAFE, KISS, convertible notes, etc.)
common clauses mostly discussed by founders and investors (e.g., liquidation preference, exit, corporate governance, anti-dilution, limitation to the transfer of shares, etc.)
best practices and new trends.
Investimenti sostenibili 4.0: an aid scheme of around €677 million for new innovative and sustainable investments will be available to SMEs from May 18, 2022, with the aim of fostering the technological transformation of businesses
Investimenti sostenibili 4.0: an aid scheme of around €677 million for new innovative and sustainable investments will be available to SMEs from May 18, 2022, with the aim of fostering the technological transformation of businesses
16
Mar 22
Startups and Sustainability: Interview with Fili Pari
At this pivotal moment when sustainability is more of a focus than ever, we are pleased to offer the next installment in our “Startups and Sustainability” interview series.
3
Mar 22
Investing in biotech
At the end of last year, our partners Luca Gambini and Antonia Verna talked to Elizabeth Robinson, vice chairman of the board of Indaco Venture Partners, and Ciro Spedaliere, partner in Claris Ventures SGR S.p.A., about the last trends in venture capital investments in the biotech sector.
